Revised SPCs: Simponi (golimumab) solution for injection in pre-filled pen or syringe (all strengths)

SPCs updated to include Kaposi’s sarcoma (a rare type of cancer caused by a virus, which can affect the skin and mouth and potentially the internal organs) as an adverse effect of treatment of unknown frequency.

Source:

electronic Medicines compendium